Whole-Transcriptome Analysis of Docetaxel-Resistant LNCaP and C4-2B Prostate Cancer Cells Reveals Alternative Splicing and Non-Coding RNA Dimensions of Taxane Resistance
Cells · 13.11.2026 · 15 (22) · 2070
DOI: 10.3390/cells15222070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 13.11.2026. Verfasst von Luciano O. Souza und 1 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sawmill Owner Jeppe Juhl and Wife Ovita Juhl Memorial Grant.
Abstract (Originalsprache)
Docetaxel (DTX) is a first-line chemotherapy for metastatic castration-resistant prostate cancer, but acquired resistance is near-universal. We previously generated isogenic DTX-resistant LNCaP and C4-2B cell line derivatives and profiled them using Affymetrix Clariom D arrays, but our initial analysis was limited to gene-level differential expression highlighting ABCB1. Here, we re-analysed all twelve arrays (two lineages × parental/resistant × three passages) using a linear-model framework to exploit exon/junction-level and non-coding transcriptome data. We confirmed the core resistance signature (ABCB1, VTRNA1-1, TRAIL/TNFSF10) and identified a shared 587-gene resistance programme within which mitotic and microtubule-based-movement genes were coordinately down-regulated. Splice analysis revealed 315 high-confidence reciprocal exon-usage events (including NTNG1, CTNND1, MYO6, MAT2A). Biotype-resolved analysis identified 123 resistance-associated lncRNAs (including LINC00152/CYTOR), with co-regulated antisense/sense pairs (e.g., MME-AS1/MME, ATP1B3-AS1/ATP1B3) suggesting candidate local (sense–antisense) regulatory relationships. The proliferation programme aligned with growth kinetics, as cell-cycle/mitotic genes were down-regulated in slower-growing C4-2BR cells. By fully exploiting Clariom D, we extend the molecular portrait of DTX resistance beyond gene expression to coordinated alternative splicing and structured non-coding responses.
Förderung
- Sawmill Owner Jeppe Juhl and Wife Ovita Juhl Memorial Grant
Zitieren
APA
Souza, L. O., & Moreira, J. M. A. (2026). Whole-Transcriptome Analysis of Docetaxel-Resistant LNCaP and C4-2B Prostate Cancer Cells Reveals Alternative Splicing and Non-Coding RNA Dimensions of Taxane Resistance. Cells, 15(22), 2070. https://doi.org/10.3390/cells15222070
Vancouver
Souza LO, Moreira JMA. Whole-Transcriptome Analysis of Docetaxel-Resistant LNCaP and C4-2B Prostate Cancer Cells Reveals Alternative Splicing and Non-Coding RNA Dimensions of Taxane Resistance. Cells. 2026;15(22):2070. doi:10.3390/cells15222070
BibTeX
@article{Souza2026,
author = {Souza, Luciano O. and Moreira, José M. A.},
title = {Whole-Transcriptome Analysis of Docetaxel-Resistant LNCaP and C4-2B Prostate Cancer Cells Reveals Alternative Splicing and Non-Coding RNA Dimensions of Taxane Resistance},
journal = {Cells},
year = {2026},
volume = {15},
number = {22},
pages = {2070},
doi = {10.3390/cells15222070}
}
EUVIMED